Anders Svenningsson

Anders Svenningsson

UNVERIFIED PROFILE

Are you Anders Svenningsson?   Register this Author

Register author
Anders Svenningsson

Anders Svenningsson

Publications by authors named "Anders Svenningsson"

Are you Anders Svenningsson?   Register this Author

58Publications

964Reads

8Profile Views

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry.

Metabolomics 2020 Feb 12;16(2):26. Epub 2020 Feb 12.

Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala University Hospital, Entrance 61, 3rd Floor, Dag Hammarskjölds Väg 18, 751 85, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11306-020-1648-5DOI Listing
February 2020

Reply to Sun et al.

Pain 2019 12;160(12):2898-2899

Department of Medical Sciences, Chemical Chemistry, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/j.pain.0000000000001699DOI Listing
December 2019

Serum sickness following rituximab therapy in multiple sclerosis.

Neurol Clin Pract 2019 Dec;9(6):519-521

Department of Neurology (TH), Akershus University Hospital, Lørenskog; Institute of Clinical Medicine (TH), University of Oslo, Norway; Karolinska Institutet (AF-H), Department of Clinical Neuroscience, Center for Molecular Medicine (CMM), Karolinska University Hospital Solna; and Department of Clinical Sciences (AF-H, AS), Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/CPJ.0000000000000685DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927430PMC
December 2019

Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.

J Neurol 2019 Sep 31;266(9):2208-2215. Epub 2019 May 31.

Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-019-09397-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687702PMC
September 2019

Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Mult Scler 2019 Aug 8:1352458519866600. Epub 2019 Aug 8.

Department of Clinical Neuroscience, Center for Molecular Medicine (CMM), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458519866600
Publisher Site
http://dx.doi.org/10.1177/1352458519866600DOI Listing
August 2019

[Diagnostic challenge in a man with intractable hiccups and vomiting: a case of neuromyelitis optica spectrum disorder (NMOSD)].

Lakartidningen 2019 Aug 13;116. Epub 2019 Aug 13.

Danderyds sjukhus - Röntgenavd Stockholm, Sweden Danderyds sjukhus - Röntgenavd Stockholm, Sweden.

View Article

Download full-text PDF

Source
August 2019

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

JAMA Neurol 2019 Jun 17. Epub 2019 Jun 17.

UCL Institute of Neurology, Queen Square, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2019.1534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580449PMC
June 2019

Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.

Acta Neurol Scand 2019 May 5;139(5):462-468. Epub 2019 Mar 5.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13078DOI Listing
May 2019

Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.

Neurology 2019 02 11;92(7):313-314. Epub 2019 Jan 11.

From the Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square; UK Dementia Research Institute at UCL (H.Z.), London; and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Danderyd Hospital AB, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006906DOI Listing
February 2019

Inflammatory activity and vitamin D levels in an MS population treated with rituximab.

Mult Scler J Exp Transl Clin 2019 Jan-Mar;5(1):2055217319826598. Epub 2019 Feb 11.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217319826598DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378455PMC
February 2019

Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.

Neurology 2018 11 10;91(20):e1893-e1901. Epub 2018 Oct 10.

From the Department of Pharmacology and Clinical Neuroscience (J. Bergman, J.D.G., T.B., A.S.), Umeå University; Department of Neurosciences (J. Burman, E.J.), Uppsala University; Department of Psychiatry and Neurochemistry (H.Z.), Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, Queen Square; UK Dementia Research Institute at UCL (H.Z.), London; and Department of Clinical Sciences (A.S.), Karolinska Institute Danderyd Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000006500DOI Listing
November 2018

Cortico-juxtacortical and periventricular lesions and MS diagnostic criteria.

Neurology 2017 12 3;89(23):2308-2309. Epub 2017 Nov 3.

From the Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden; and Queen Square MS Centre (O.C.), UCL Institute of Neurology, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004725DOI Listing
December 2017

Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

Neurology 2017 Nov 27;89(22):2230-2237. Epub 2017 Oct 27.

From the Department of Clinical Neuroscience (L.N., M.A., C.M., J.L.) and Department of Psychiatry and Neurochemistry (H.Z., K.B.), Institute of Neuroscience and Physiology at Sahlgrenska Academy, University of Gothenburg; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, London, UK; Department of Pharmacology and Clinical Neuroscience (P.S.), Umeå University; University Department of Clinical Neuroscience (M.K., T.O., F.P.), Neuroimmunology Unit, and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Stockholm; and Department of Neurology (M.G.), Faculty of Medicine and Health, Örebro University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000004683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705244PMC
November 2017

Improved treatment satisfaction after switching therapy to rituximab in relapsing-remitting MS.

Mult Scler 2017 Aug 25;23(9):1249-1257. Epub 2016 Oct 25.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden/Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458516676643DOI Listing
August 2017

Brain Parenchymal Fraction in Healthy Adults-A Systematic Review of the Literature.

PLoS One 2017 17;12(1):e0170018. Epub 2017 Jan 17.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0170018PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240949PMC
August 2017

Brain parenchymal fraction in an age-stratified healthy population - determined by MRI using manual segmentation and three automated segmentation methods.

J Neuroradiol 2016 Dec 5;43(6):384-391. Epub 2016 Oct 5.

Department of Pharmacology and Clinical Neuroscience, Section of Neuroscience, Umeå University, 90185 Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neurad.2016.08.002DOI Listing
December 2016

Reply.

Ann Neurol 2016 11 27;80(5):791-792. Epub 2016 Sep 27.

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24767DOI Listing
November 2016

Rituximab in multiple sclerosis: A retrospective observational study on safety and efficacy.

Neurology 2016 Nov 19;87(20):2074-2081. Epub 2016 Oct 19.

From the Department of Pharmacology and Clinical Neuroscience (J.S., R.S., P.I.-J., M.V., P.S., A.S.), Umeå University; Departments of Clinical Neuroscience (R.S., P.A., A.B., K.F., F.P.) and Clinical Sciences, Danderyd Hospital (A.S.), Karolinska Institutet, Stockholm; and Department of Clinical Neuroscience (L.N., C.M., M.A., J.L.), Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109942PMC
November 2016

How to minimize the risk for headache? A lumbar puncture practice questionnaire study.

Ideggyogy Sz 2016 Nov;69(11-12):397-402

Umeå University, Department of Pharmacology and Clinical Neuroscience, Section for Neurology Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18071/isz.69.0397DOI Listing
November 2016

Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 2;3(5):e271. Epub 2016 Aug 2.

Department of Pharmacology and Clinical Neuroscience (J.B., A.D., J.G., T.B., A.S.), Umeå University; Institute of Neuroscience and Physiology (H.Z., K.B.), Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal; Clinical Neurochemistry Laboratory (H.Z., K.B.), Sahlgrenska University Hospital, Mölndal, Sweden; Department of Molecular Neuroscience (H.Z.), UCL Institute of Neurology, Queen Square, London, UK; UmanDiagnostics AB (N.N.), Umeå; and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Danderyd Hospital AB, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000271DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972001PMC
October 2016

Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab.

Neurology 2016 Jul 17;87(2):141-7. Epub 2016 Jun 17.

From the Department of Pharmacology and Clinical Neuroscience, Unit of Neurology, Östersund (P.d.F., K.L.), Umeå University; Department of Radiation Sciences, Diagnostic Radiology (R.B., T.L.), and Department of Pharmacology and Clinical Neuroscience (A.D., J.B., P.S., A.S.), Umeå University; Department of Neurology, School of Medical Sciences (M.G.), Department of Radiology (W.K.), Faculty of Medicine and Health, Örebro University; Unit of Research, Education and Development (L.S.), Region Jämtland Härjedalen; and Department of Clinical Sciences (A.S.), Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000002832DOI Listing
July 2016

Rituximab versus fingolimod after natalizumab in multiple sclerosis patients.

Ann Neurol 2016 Jun 20;79(6):950-8. Epub 2016 Apr 20.

Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.24651DOI Listing
June 2016

Cerebrospinal fluid concentration of Galectin-9 is increased in secondary progressive multiple sclerosis.

J Neuroimmunol 2016 Mar 16;292:40-4. Epub 2016 Jan 16.

Department of Pharmacology and Clinical Neuroscience, Umeå University and University Hospital of Northern Sweden, Umeå, Sweden; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2016.01.008DOI Listing
March 2016

Rituximab in paediatric onset multiple sclerosis: a case series.

J Neurol 2016 Feb 24;263(2):322-326. Epub 2015 Nov 24.

Department of Pharmacology and Clinical Neuroscience, Section of Neurology, Umeå University, 90187, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-015-7979-xDOI Listing
February 2016

Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.

Neurol Neuroimmunol Neuroinflamm 2016 Feb 7;3(1):e191. Epub 2016 Jan 7.

Neuroimmunology Unit (F.A.N., M.K., S.A., T.O., F.P.), Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; Institute of Infection, Immunity and Inflammation (C.E., C.L.), University of Glasgow, UK; Department of Pharmacology and Clinical Neuroscience (J.B., A.M.D., A.S.) and Neurosurgery (T.B.), Umeå University, Sweden; and Danish Multiple Sclerosis Center (J.R.C., F.S.), Department of Neurology, Rigshospitalet, University of Copenhagen, Denmark.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000191DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708925PMC
February 2016

Improved working ability in a contemporary MS population compared with a historic non-treated MS population in the same geographic area of Sweden.

Mult Scler J Exp Transl Clin 2015 Jan-Dec;1:2055217315608203. Epub 2015 Sep 22.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2055217315608203DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433506PMC
September 2015

Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.

Neurol Neuroimmunol Neuroinflamm 2015 Apr 26;2(2):e79. Epub 2015 Feb 26.

Department of Pharmacology and Clinical Neuroscience (A.S., J.B., A.D., M.V., J.G., T.B.) and Department of Radiation Sciences (R.B., T.L.), Diagnostic Radiology, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000079DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345631PMC
April 2015

Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.

Front Neurol 2015 23;6:18. Epub 2015 Feb 23.

Department of Pharmacology and Clinical Neuroscience, University Hospital of Northern Sweden, Umeå University , Umeå , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2015.00018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337367PMC
March 2015

Age-dependent effects on the treatment response of natalizumab in MS patients.

Mult Scler 2015 Jan 27;21(1):48-56. Epub 2014 May 27.

Karolinska University Hospital, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458514536085DOI Listing
January 2015

Lumbar puncture preferences among Swedish neurologists.

Neurol Res 2015 Jan 12;37(1):92-4. Epub 2014 Sep 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/1743132814Y.0000000442DOI Listing
January 2015

The cerebrospinal fluid cytokine signature of multiple sclerosis: a homogenous response that does not conform to the Th1/Th2/Th17 convention.

J Neuroimmunol 2014 Dec 18;277(1-2):153-9. Epub 2014 Oct 18.

Department of Immunology, Genetics and Pathology, Science for Life Laboratories, Uppsala University, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.005DOI Listing
December 2014

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

J Neurol Neurosurg Psychiatry 2014 Oct 19;85(10):1116-21. Epub 2014 Feb 19.

Department of Neuroscience, Uppsala University, Uppsala, Sweden Department of Neurology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2013-307207DOI Listing
October 2014

Reduced sick leave in multiple sclerosis after one year of natalizumab treatment. A prospective ad hoc analysis of the TYNERGY trial.

Mult Scler 2014 07 30;20(8):1095-101. Epub 2013 Dec 30.

Department of Pharmacology and Clinical Neuroscience, Section of Neuroscience, Umeå University, Sweden

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513517590DOI Listing
July 2014

Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis.

Mult Scler 2014 Jan 23;20(1):43-50. Epub 2013 May 23.

Department of Clinical Neuroscience and Rehabilitation, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458513490544DOI Listing
January 2014

Improved ability to work after one year of natalizumab treatment in multiple sclerosis. Analysis of disease-specific and work-related factors that influence the effect of treatment.

Mult Scler 2013 Apr 25;19(5):622-30. Epub 2012 Sep 25.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458512461391DOI Listing
April 2013

Fatal neuroinflammation in a case of multiple sclerosis with anti-natalizumab antibodies.

Neurology 2013 Mar 6;80(10):965-7. Epub 2013 Feb 6.

Department of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0b013e3182840be3DOI Listing
March 2013

Humoral immune response to influenza vaccine in natalizumab-treated MS patients.

Neurol Res 2012 Sep 16;34(7):730-3. Epub 2012 Jun 16.

Department of Pharmacology and Clinical Neuroscience, Section of Neuroscience, Umeå University, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1179/1743132812Y.0000000059DOI Listing
September 2012

[Treatment of status epilepticus].

Lakartidningen 2012 Jun 5-19;109(23-24):1170-1

Norrlands universitetssjukus, Umeå.

View Article

Download full-text PDF

Source
August 2012

Neurofilament light as a prognostic marker in multiple sclerosis.

Mult Scler 2010 Mar 19;16(3):287-92. Epub 2010 Jan 19.

Department of Neurology, Umeå University Hospital, S-90185 Umeå, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458509359725DOI Listing
March 2010